71455-86-2 Usage
Specific content
A chemical compound with a complex structure
Specific content
A widely recognized name for the compound
Specific content
A drug category that includes medications used to reduce inflammation and pain
Specific content
The primary purpose of Aceclofenac in treating various joint and musculoskeletal disorders
Specific content
How Aceclofenac works by reducing the chemicals involved in the inflammatory response
Specific content
A related NSAID with similar analgesic and anti-inflammatory properties
Specific content
Adverse reactions that may occur with Aceclofenac use
Specific content
Guidance for safe usage of Aceclofenac to minimize risks and side effects
Classification
Nonsteroidal anti-inflammatory drug (NSAID)
Medical uses
Relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis
Mechanism of action
Inhibiting the production of prostaglandins
Derivative
Diclofenac
Side effects
Gastrointestinal irritation and other potential side effects
Precaution
Use with caution and under the supervision of a healthcare professional
Check Digit Verification of cas no
The CAS Registry Mumber 71455-86-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,5 and 5 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 71455-86:
(7*7)+(6*1)+(5*4)+(4*5)+(3*5)+(2*8)+(1*6)=132
132 % 10 = 2
So 71455-86-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H19ClN2O4/c1-12-4-3-5-13(2)18(12)22(11-16(23)21-10-17(24)25)19(26)14-6-8-15(20)9-7-14/h3-9H,10-11H2,1-2H3,(H,21,23)(H,24,25)
71455-86-2Relevant academic research and scientific papers
N-(Substituted amino)alkanoyl-aminoalkanoic acids and salts, their use and their compositions
-
, (2008/06/13)
N-substituted ω-aminoalkanoyl-ω-aminoalkanoic acids and their pharmacologically-acceptable salts (with a base) are useful, e.g., in pharmaceutical-composition form for the treatment or prophylaxis of diseases which are based on inadequate performance of the pancreas, the bile and/or the liver. The compounds are prepared, e.g., by reacting an N-(mono- or di-substituted) ω-amino-alkanoic acid with an N-(unsubstituted or monosubstituted) ω-aminoalkanoic acid.
